R. Nolan Townsend
2023
In 2023, R. Nolan Townsend earned a total compensation of $1.7M as Chief Executive Officer and Director at Lexeo Therapeutics, a 146% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $347,880 |
|---|---|
| Option Awards | $872,883 |
| Salary | $508,000 |
| Other | $8,455 |
| Total | $1,737,218 |
Townsend received $872.9K in option awards, accounting for 50% of the total pay in 2023.
Townsend also received $347.9K in non-equity incentive plan, $508K in salary and $8.5K in other compensation.
Rankings
In 2023, R. Nolan Townsend's compensation ranked 643rd out of 2,978 executives tracked by ExecPay. In other words, Townsend earned more than 78.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 643 out of 2,978 | 78th |
Division Manufacturing | 359 out of 1,637 | 78th |
Major group Chemicals And Allied Products | 247 out of 906 | 73rd |
Industry group Drugs | 243 out of 869 | 72nd |
Industry Biological Products, Except Diagnostic Substances | 82 out of 211 | 61st |
Source: SEC filing on April 26, 2024.
Townsend's colleagues
We found three more compensation records of executives who worked with R. Nolan Townsend at Lexeo Therapeutics in 2023.